Cardiff Oncology, Inc.

CRDF

Held by 2 specialist biotech funds

High short interest · No specialist buying

Share on X

Fund Holdings

Commodore Capital

OrbiMed Advisors

Position Trend

May 15, 2025

$18.7M

2 funds

Aug 14, 2025

$0

0 funds

Nov 14, 2025

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 4 quarters

Short Interest

High short interest

Short Shares

17.42M

Change

-3.1%

Days to Cover

23.3

% of Float

26.1%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13G/ARA Capital Management0.0%Feb 10, 2021

SC 13GRA Capital Management10.9%Oct 9, 2020

Position Details

Commodore CapitalEXITFeb 17, 2026

Shares: 0Value: N/A

OrbiMed AdvisorsEXITFeb 17, 2026

Shares: 0Value: N/A

+ 6more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

AMLX2 funds CTMX2 funds ANRO2 funds COGT2 funds AVTX2 funds CELC2 funds MNMD2 funds PALI2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: